Waldemar Debinski

Affiliations: 
Molecular Genetics & Genomics Wake Forest University, Winston-Salem, NC, United States 
Area:
Molecular Biology, Cell Biology, Biochemistry
Google:
"Waldemar Debinski"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Abdulhaleem M, Ruiz J, O'Neill S, et al. (2023) Collagen deposition within brain metastases is associated with leptomeningeal failure after 
cavity-directed radiosurgery. Neuro-Oncology Advances. 5: vdac186
Lyu Q, Namjoshi SV, McTyre E, et al. (2022) A transformer-based deep-learning approach for classifying brain metastases into primary organ sites using clinical whole-brain MRI images. Patterns (New York, N.Y.). 3: 100613
Helis CA, Prim SN, Cramer CK, et al. (2022) Clinical outcomes of dose-escalated re-irradiation in patients with recurrent high-grade glioma. Neuro-Oncology Practice. 9: 390-401
Sharma P, Sonawane P, Herpai D, et al. (2020) Multireceptor targeting of glioblastoma. Neuro-Oncology Advances. 2: vdaa107
Renfrow JJ, Soike MH, West JL, et al. (2020) Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Scientific Reports. 10: 15195
Hassan MS, Pullikuth A, Nelson KC, et al. (2020) Beta2-adrenoreceptor signaling increases therapy-resistance in prostate cancer by upregulating MCL1. Molecular Cancer Research : McR
Rossmeisl JH, Herpai D, Quigley M, et al. (2020) Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas. Neuro-Oncology
Werner CK, Nna UJ, Sun H, et al. (2020) Expression of the of the androgen receptor governs radiation resistance in a subset of glioblastomas vulnerable to anti-androgen therapy. Molecular Cancer Therapeutics
Sharma P, Roberts C, Herpai D, et al. (2020) Drug Conjugates for Targeting Eph Receptors in Glioblastoma. Pharmaceuticals (Basel, Switzerland). 13
Sanders S, Debinski W. (2020) Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma. International Journal of Molecular Sciences. 21
See more...